Psychopharmacology Update

October 29, 2022

Optional Pre-Conference Workshops and Keynote Presentation on October 28

 

The Westin Cincinnati Hotel
Cincinnati, Ohio

 

swoosh
swoosh

ACCREDITATION

TARGET AUDIENCE

This activity is intended for pediatric, general and geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers and other mental health professionals engaged in the care of patients with psychiatric disorders.

 

LEARNING OBJECTIVES

As a result of participating in this activity, participants should be able to: [LIST] [ITEM] Recognize overlapping symptoms and devise a treatment approach to address the individual patient’s comorbidities [ITEM]Design treatment plans for various mood and psychotic disorders [ITEM]Demonstrate a working knowledge of medication combinations and adjunctive therapies with the best evidence of efficacy to integrate practice guidelines for their treatment [ITEM]Utilize pharmacotherapy in the treatment of diverse patients with mood and psychotic disorders who also have other comorbid conditions. [/LIST]

 

ACCREDITATION STATEMENTS

[bold]Physician Accreditation [/bold] This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Global Academy for Medical Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. [bold]Physician Credit Designation [/bold] The University of Cincinnati designates this Live Activity for a maximum of 12.25 [italic]AMA PRA Category 1 Credit(s)™[/italic]. (5.25 for the general sessions and 7.0 for attending the pre-conference workshops and Keynote Presentation) Physicians should claim only the credit commensurate with the extent of their participation in the activity. [JALOGO][PIM] [bold]Nursing Accreditation[/bold] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [bold]Continuing Nursing Education[/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 12.25 (5.25 for the general sessions and 7.0 for attending the pre-conference workshops and Keynote Presentation) contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be determined and indicated on your certificate. [bold]Physician Assistants Credit Designation[/bold] The American Academy of Physician Assistants (AAPA) accepts [italic]AMA PRA Category 1 Credit(s)™ [/italic]from organizations accredited by the ACCME. [bold]American Board of Psychiatry and Neurology Maintenance of Certification[/bold] The American Board of Psychiatry and Neurology has reviewed the 2022 Psychopharmacology Update and has approved this program as part of a comprehensive CME program, which is mandated by the ABMS as a necessary component of maintenance of certification (MOC). The activity awards 12.25 [italic]AMA PRA Category 1 Credits[/italic]. These credits are ABPN-approved as Self-Assessment credits.